TY - CHAP PY - 2013 DA - 2013// BT - Global strategy for the diagnosis, management and prevention of COPD ID - ref1 ER - TY - JOUR AU - Tashkin, D. P. AU - Celli, B. AU - Senn, S. AU - Burkhart, D. AU - Kesten, S. AU - Menjoge, S. AU - Decramer, M. PY - 2008 DA - 2008// TI - A 4-year trial of tiotropium in chronic obstructive pulmonary disease JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0805800 DO - 10.1056/NEJMoa0805800 ID - Tashkin2008 ER - TY - CHAP PY - 2013 DA - 2013// BT - Bretaris Genuair (aclidinium bromide) summary of product characteristics ID - ref3 ER - TY - CHAP PY - 2013 DA - 2013// BT - Tudorza pressair (aclidinium bromide) US prescribing information ID - ref4 ER - TY - CHAP PY - 2013 DA - 2013// BT - Seebri Breezhaler (glycopyrronium bromide) Summary of Product Characteristics ID - ref5 ER - TY - CHAP PY - 2012 DA - 2012// BT - Media release: Novartis receives European commission approval for once-daily Seebri® Breezhaler® as maintenance COPD treatment in the EU ID - ref6 ER - TY - JOUR AU - Beeh, K. M. AU - Singh, D. AU - Di, S. L. AU - Drollmann, A. PY - 2012 DA - 2012// TI - Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial JO - Int J Chron Obstruct Pulmon Dis VL - 7 UR - https://doi.org/10.2147/COPD.S32451 DO - 10.2147/COPD.S32451 ID - Beeh2012 ER - TY - JOUR AU - D’Urzo, A. AU - Ferguson, G. T. AU - Van Noord, J. A. AU - Hirata, K. AU - Martin, C. AU - Horton, R. AU - Lu, Y. AU - Banerji, D. AU - Overend, T. PY - 2011 DA - 2011// TI - Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial JO - Respir Res VL - 12 UR - https://doi.org/10.1186/1465-9921-12-156 DO - 10.1186/1465-9921-12-156 ID - D’Urzo2011 ER - TY - JOUR AU - Kerwin, E. AU - Hebert, J. AU - Gallagher, N. AU - Martin, C. AU - Overend, T. AU - Alagappan, V. K. AU - Lu, Y. AU - Banerji, D. PY - 2012 DA - 2012// TI - Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study JO - Eur Respir J VL - 40 UR - https://doi.org/10.1183/09031936.00040712 DO - 10.1183/09031936.00040712 ID - Kerwin2012 ER - TY - JOUR AU - Beeh, K. M. AU - Beier, J. AU - Donohue, J. F. PY - 2012 DA - 2012// TI - Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium JO - Respir Res VL - 13 UR - https://doi.org/10.1186/1465-9921-13-52 DO - 10.1186/1465-9921-13-52 ID - Beeh2012 ER - TY - CHAP PY - 2010 DA - 2010// BT - Global strategy for the diagnosis, management and prevention of COPD ID - ref11 ER - TY - JOUR AU - Miller, M. R. AU - Crapo, R. AU - Hankinson, J. AU - Brusasco, V. AU - Burgos, F. AU - Casaburi, R. AU - Coates, A. AU - Enright, P. AU - van der Grinten, C. P. AU - Gustafsson, P. PY - 2005 DA - 2005// TI - General considerations for lung function testing JO - Eur Respir J VL - 26 UR - https://doi.org/10.1183/09031936.05.00034505 DO - 10.1183/09031936.05.00034505 ID - Miller2005 ER - TY - JOUR AU - Donohue, J. F. PY - 2005 DA - 2005// TI - Minimal clinically important differences in COPD lung function JO - COPD VL - 2 UR - https://doi.org/10.1081/COPD-200053377 DO - 10.1081/COPD-200053377 ID - Donohue2005 ER - TY - JOUR AU - Witek, T. J. AU - Mahler, D. A. PY - 2003 DA - 2003// TI - Minimal important difference of the transition dyspnoea index in a multinational clinical trial JO - Eur Respir J VL - 21 UR - https://doi.org/10.1183/09031936.03.00068503a DO - 10.1183/09031936.03.00068503a ID - Witek2003 ER - TY - JOUR AU - Jones, P. W. PY - 2005 DA - 2005// TI - St. George’s Respiratory Questionnaire: MCID JO - COPD VL - 2 UR - https://doi.org/10.1081/COPD-200050513 DO - 10.1081/COPD-200050513 ID - Jones2005 ER - TY - JOUR AU - Donohue, J. F. AU - Anzueto, A. AU - Brooks, J. AU - Mehta, R. AU - Kalberg, C. AU - Crater, G. PY - 2012 DA - 2012// TI - A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD JO - Respir Med VL - 106 UR - https://doi.org/10.1016/j.rmed.2012.03.012 DO - 10.1016/j.rmed.2012.03.012 ID - Donohue2012 ER - TY - JOUR AU - Donohue, J. F. AU - Fogarty, C. AU - Lotvall, J. AU - Mahler, D. A. AU - Worth, H. AU - Yorgancioglu, A. AU - Iqbal, A. AU - Swales, J. AU - Owen, R. AU - Higgins, M. PY - 2010 DA - 2010// TI - Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium JO - Am J Respir Crit Care Med VL - 182 UR - https://doi.org/10.1164/rccm.200910-1500OC DO - 10.1164/rccm.200910-1500OC ID - Donohue2010 ER - TY - JOUR AU - Hanania, N. A. AU - Boota, A. AU - Kerwin, E. AU - Tomlinson, L. AU - Is-Mize, K. PY - 2009 DA - 2009// TI - Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: results from a 6-week, randomized, placebo-controlled, clinical trial JO - Drugs VL - 69 UR - https://doi.org/10.2165/00003495-200969090-00005 DO - 10.2165/00003495-200969090-00005 ID - Hanania2009 ER - TY - JOUR AU - Jung, K. S. AU - Park, H. Y. AU - Park, S. Y. AU - Kim, S. K. AU - Kim, Y. K. AU - Shim, J. J. AU - Moon, H. S. AU - Lee, K. H. AU - Yoo, J. H. AU - Lee, S. D. PY - 2012 DA - 2012// TI - Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study JO - Respir Med VL - 106 UR - https://doi.org/10.1016/j.rmed.2011.09.004 DO - 10.1016/j.rmed.2011.09.004 ID - Jung2012 ER - TY - JOUR AU - Higgins, V. AU - Broomfield, S. AU - Pollard, R. AU - Fermer, S. PY - 2013 DA - 2013// TI - Impact of morning symptoms on the working lives of COPD patients [abstract] JO - COPD VL - 10 ID - Higgins2013 ER - TY - JOUR AU - Partridge, M. R. AU - Karlsson, N. AU - Small, I. R. PY - 2009 DA - 2009// TI - Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey JO - Curr Med Res Opin VL - 25 UR - https://doi.org/10.1185/03007990903103006 DO - 10.1185/03007990903103006 ID - Partridge2009 ER - TY - JOUR AU - Bourbeau, J. AU - Bartlett, S. J. PY - 2008 DA - 2008// TI - Patient adherence in COPD JO - Thorax VL - 63 UR - https://doi.org/10.1136/thx.2007.086041 DO - 10.1136/thx.2007.086041 ID - Bourbeau2008 ER - TY - JOUR AU - Vestbo, J. AU - Anderson, J. A. AU - Calverley, P. M. AU - Celli, B. AU - Ferguson, G. T. AU - Jenkins, C. AU - Knobil, K. AU - Willits, L. R. AU - Yates, J. C. AU - Jones, P. W. PY - 2009 DA - 2009// TI - Adherence to inhaled therapy, mortality and hospital admission in COPD JO - Thorax VL - 64 UR - https://doi.org/10.1136/thx.2009.113662 DO - 10.1136/thx.2009.113662 ID - Vestbo2009 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2466/14/4/prepub UR - http://www.biomedcentral.com/1471-2466/14/4/prepub ID - ref24 ER -